Farallon Capital Management »

Ceridian Hcm Hldg shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Ceridian Hcm Hldg shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Ceridian Hcm Hldg

Tip: Access up to 7 years of quarterly data

All positions including Ceridian Hcm Hldg held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ceridian Hcm Hldg by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $202M 2.9M 69.16

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Revolution Medicines (RVMD)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Aon Shs Cl A (AON)
Natera (NTRA)
Boston Scientific Corporation (BSX)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Exelixis (EXEL)
Bridgebio Pharma (BBIO)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Protagonist Therapeutics (PTGX)
Wabtec Corporation (WAB)
UnitedHealth (UNH)
Cyberark Software SHS (CYBR)

View all positions for Farallon Capital Management

Top funds holding Ceridian Hcm Hldg

Vanguard Group
BlackRock
Henderson Group
Goldman Sachs Group
State Street Corporation
Pentwater Capital Management
Dragoneer Investment
Glazer Capital
Geode Capital Management
Norges Bank Investment Management
Fil
Farallon Capital Management
Invesco
Bank of Nova Scotia
Syquant Capital Sas

View all funds holding Ceridian Hcm Hldg